Opinion: Long-acting medications for opioid addiction help patients control their future, unreliable selves

Effective medications that stay active in the body for weeks or months can help people addicted to opioids parlay transitory desires to stop using these drugs into lasting recovery from…
A patient takes buprenorphine as part of a medication-assisted therapy program in Imphal, India.

When my patient, Marcus, wakes up shaky, exhausted, and ashamed each morning, he wants to quit using heroin more than anything else in the world. But that’s not the Marcus who is making decisions a few hours later.

Like countless people with addictions I have met in my career as a clinician and researcher, Marcus (not his real name) makes repeated, sincere resolutions to stop his drug use only to have his future self return to it a month, a week, a day, even an hour

Stai leggendo un'anteprima, registrati per continuare a leggere.

Altro da STAT

STAT4 min lettiSociety
It’s Been Sequenced. It’s Spread Across Borders. Now The New Pneumonia-causing Virus Needs A Name
Ebola, SARS, swine flu, MERS. With the reality that a previously unknown animal virus has started infecting people, the world faces a recurring question: What does one call it? The pneumonia-causing virus, which is spreading rapidly in China and beyo
STAT4 min lettiScience
DNA Sleuths Read The Coronavirus Genome, Tracing Its Origins And Looking For Dangerous Mutations
As epidemiologists race to contain the outbreak of a novel #coronavirus, they’re getting backup from the explosion in genetic technologies
STAT1 min letti
Listen: The Latest On The China Virus, Sarepta’s Ongoing FDA Saga, And Biotech At Davos
Are we dealing with a SARS redux? Has the FDA lost its teeth? And what do billionaires talk to each other about? We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, STAT’s Helen Branswell joins us